Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive,poor-prognosis subgroup of high-grade serous ovarian carcinoma |
| |
| Authors: | Catarina Alisa Liebscher Judith Prinzler Bruno Valentin Sinn Jan Budczies Carsten Denkert Aurelia Noske Jalid Sehouli Elena Ioana Braicu Manfred Dietel Silvia Darb-Esfahani |
| |
| Affiliation: | 1. Institute of Pathology, Charité Universitätsmedizin Berlin, 10117 Berlin, Germany;2. Institute of Pathology, Universitätsspital Zürich, 8091 Zurich, Switzerland;3. Department of Gynecology, Charité Universitätsmedizin Berlin, 13353 Berlin, Germany |
| |
| Abstract: | |
| |
| Keywords: | ALDH1, aldehyde dehydrogenase 1 BRCA1, breast cancer antigen 1 CI, confidence interval CSC, cancer stem cell EGFR, epidermal growth factor receptor FFPE, formalin-fixed, paraffin-embedded FIGO, International Federation of Gynaecology and Obstetrics H& E, hematoxylin and eosin HGSC, high-grade serous carcinoma HR, hazard ratio IRS, immunoreactivity score MEC, mammary epithelial cells OCTIPS, Ovarian Cancer Therapy Innovative Models Prolong Survival OS, overall survival TMA, tissue microarray TNBC, triple-negative breast cancer |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
